Navigation Links
Current Study Offers Window into Automation & Outsourcing Practices Within Top Pharmaceutical Market Research Groups
Date:2/28/2012

CHAPEL HILL, N.C., Feb. 28, 2012 /PRNewswire/ -- In an effort to maximize business impact and improve efficiency with limited resources, pharma and biotech market research leaders must constantly evaluate the manner in which they outsource their labor. More specifically, executives need to understand the optimal balance of external contract employees in order to reduce redundancy and enhance productivity in the quickly changing healthcare industry.

To identify innovative strategies and approaches for maximizing market research efficiency through the use of outsourced labor and process automation, Best Practices, LLC, a world-leader in biopharmaceutical benchmarking research, has launched an exciting new study called "Using Outsourced Personnel and Automation to Maximize Market Research Efficiency."

Preliminary results from this ongoing study suggest that outsourced labor for secondary report preparation – as compared to other key market research areas – will increase the most in the next 2-3 years.  Best Practices is also monitoring additional emerging data trends around time spent managing outsourced personnel and leading processes for enhancing the impact of offsite personnel.

Study topics include:

  • Outsourcing Profile
  • Reasons for Outsourcing
  • Outsourcing Process: Vendor Selection and Management
  • Assessing the Strategy & Value of Outsourced Market Research Labor
  • Using Automation to Expedite the Delivery of Market Research
  • Future Changes in Outsourcing Levels

This crucial research study represents the latest contribution of Best Practices, LLC to the life science industry's staffing and investment knowledge.  While previous studies have captured key metrics to identify optimal resource levels for maximum competitiveness, regulatory and other changes have continued to erode the effectiveness of the industry's proven business model - a fact pressing executives to reconsider efficient levels of human and capital investment.

This latest study therefore offers an open benchmark opportunity for market research executives throughout the bio-pharma and medical device sectors.

To view or participate in the online survey, follow this link: http://www.surveygizmo.com/s3/800600/Market-Research-Efficiency.

For assistance or questions related to this study, contact research team leader Vahid Sanii at vsanii@best-in-class.com or (919) 767-9254. Responses are requested by Mar. 9, 2012.

There is no cost to participate, and all benchmark participants will receive the complete, blinded research results and analysis for free. This study will generate comparative metrics and executive insights that participants can use in the future to help assess what outsourcing levels and automation processes are right for different sizes of company.

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies.

The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medical Alarm Concepts Investor Update -- News on Current Initiatives
2. Updated Survival Data from Study Comparing TTF™ (Tumor Treating Fields) Therapy to Best Standard Chemotherapy for Recurrent Glioblastoma Reported at the 16th Annual Scientific Meeting of the Society for NeuroOncology
3. Current Trends and Future Directions in Physician E-Sampling Programs for the Pharmaceutical Industry
4. Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling
5. S1P1 Agonists are Currently Indicated For Treatment of Multiple Sclerosis
6. Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates
7. ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price
8. MedInformatix Practice Management and Electronic Medical Records Simplifies Texas Dermatology Practices Current and Future Operations
9. Groupe Athena, Inc. Provides Guidance on Current Orders
10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
11. Assured Pharmacy Upgrades to OTC Pink Current Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ANDOVER, Mass. and SAN CLEMENTE, Calif. ... California -based mobile pulmonary function testing company, is now ... portable PFT devices developed by ndd Medical Technologies , Inc. ... PFT testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ... CA , can get any needed testing done in the ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
Breaking Medicine News(10 mins):